biospectrumasia.com
Open in
urlscan Pro
2a02:4780:23:aee7:2fb:e4d8:e3aa:1e03
Public Scan
Submitted URL: https://app.getresponse.com/click.html?x=a62b&lc=hjHgsx&mc=IQ&s=B0Fi00j&u=Sk7tB&z=EtMxCGx&
Effective URL: https://biospectrumasia.com/
Submission: On April 03 via api from DE — Scanned from DE
Effective URL: https://biospectrumasia.com/
Submission: On April 03 via api from DE — Scanned from DE
Form analysis
7 forms found in the DOMGET /search/
<form action="/search/" method="get" class="ng-pristine ng-valid">
<input type="text" name="query" id="search_text" value="">
<input type="submit" name="" id="search_button" value="">
</form>
Name: pollForm —
<form name="pollForm" id="pollForm" ng-controller="SitePollController" ng-submit="submitPoll()" ng-model="action" ng-init="action='/poll-handle/'" class="ng-pristine ng-untouched ng-valid ng-scope">
<div class="col-md-12 col-centered pt">
<input type="hidden" name="pollQuestionId" id="pollQuestionId" value="96" ng-model="pollFormData.pollQuestionId" ng-init="pollFormData.pollQuestionId='96'" class="ng-pristine ng-untouched ng-valid">
<div class="lineb"></div>
<div class="lineg"></div>
<h4 class="blue">Survey Box</h4>
<p class="blue-link">
<a>Is the APAC region addressing accessibility and affordability of cell & gene therapies?</a>
</p>
<p class="news-heading"></p>
<!-- ngIf: optionData === undefined -->
<div class="ng-scope" ng-if="optionData === undefined">
<div class="radio">
<label><input type="radio" name="option" id="option_245" value="245" ng-model="pollFormData.pollOptionId" class="ng-pristine ng-untouched ng-valid"> Yes</label>
</div>
<div class="radio">
<label><input type="radio" name="option" id="option_246" value="246" ng-model="pollFormData.pollOptionId" class="ng-pristine ng-untouched ng-valid"> No</label>
</div>
<div class="radio">
<label><input type="radio" name="option" id="option_247" value="247" ng-model="pollFormData.pollOptionId" class="ng-pristine ng-untouched ng-valid"> May be</label>
</div>
<div class="alert alert-danger alert-dismissable ng-hide" ng-show="isPollError == '1'" id="poll-error-box">
<a href="#" class="close" data-dismiss="alert" aria-label="close">×</a> Please select an option to participate in the poll.
</div>
<!-- ngIf: pollRequestState != '0' -->
<!-- ngIf: pollRequestState == '0' --><span class="ng-scope" ng-if="pollRequestState == '0'">
<button type="submit" class="btn btn-primary">Vote</button>
</span><!-- end ngIf: pollRequestState == '0' --> <a href="/poll/96/is-the-apac-region-addressing-accessibility-and-affordability-of-cell-gene-therapies">View poll results</a> <a href="/polls/">More polls</a><br><br>
</div><!-- end ngIf: optionData === undefined -->
<!-- ngIf: optionData !== undefined -->
<!-- ngRepeat: optionDetail in optionData -->
<!-- ngIf: optionData !== undefined -->
</div>
</form>
Name: enquiryForm — POST
<form role="form" method="post" name="enquiryForm" id="enquiryForm" class="ng-pristine ng-valid">
<div class="alert alert-success" id="enquiry-alert" style="display: none;"> Thanks for contacting us! We will get in touch with you shortly. </div>
<div class="alert alert-danger" id="enquiry-error" style="display: none;"> Please fill the all fields. </div>
<div class="alert alert-danger" id="enquiry-error-msg" style="display: none;"></div>
<div class="form-group">
<label class="sr-only" for="contact-name">Name</label>
<input type="text" name="enquiryForm[name]" placeholder="Name" class="form-control" id="name">
</div>
<div class="form-group">
<label class="sr-only" for="contact-email">Email</label>
<input type="text" name="enquiryForm[email]" placeholder="Email" class="form-control" id="email">
<span class="help-block text-danger" id="enquiry-email-error" style="display: none;">Enter a valid email address.</span>
</div>
<div class="form-group">
<label class="sr-only" for="contact-subject">Phone</label>
<input type="text" name="enquiryForm[contact]" placeholder="Phone" class="form-control" id="contact">
</div>
<div class="form-group">
<label class="sr-only" for="contact-message">Message</label>
<textarea name="enquiryForm[message]" placeholder="Message" class="form-control" id="message"></textarea>
</div>
<a href="javascript:;" class="color-333" id="save-enquiry-btn" data-enquiry-url="/enquiry-handle/"><button type="button" class="btn">Send message</button></a>
<img src="/bundles/interlinksapp/assets/global/plugins/owl-carousel/assets/img/AjaxLoader.gif" id="enquiry-ajax-loader" class="hide">
</form>
Name: loginForm — POST /login/
<form role="form" action="/login/" method="post" name="loginForm" id="loginForm" onsubmit="return validateLogin();" class="ng-pristine ng-valid">
<div class="alert alert-danger" id="login-error-msg" style="display: none;"></div>
<div class="form-group">
<label class="sr-only" for="login-email">Email id</label>
<input type="email" name="loginForm[email]" placeholder="Email" class="form-control" id="login-email">
<span class="help-block text-danger" id="login-email-error" style="display: none;"></span>
</div>
<div class="form-group">
<label class="sr-only" for="login-password">Password</label>
<input type="password" name="loginForm[password]" placeholder="Password" class="form-control" id="login-password">
<span class="help-block text-danger" id="login-password-error" style="display: none;"></span>
</div>
<div class="row">
<div class="col-md-12">
<div class="form-group">
<button class="btn btn-success col-md-12" type="submit">Sign In</button>
</div>
</div>
</div>
</form>
Name: registrationForm — POST /registration/
<form role="form" action="/registration/" method="post" name="registrationForm" id="registrationForm" onsubmit="return validateRegistration();" class="ng-pristine ng-valid">
<input type="hidden" value="false" id="is-email-exist">
<input type="hidden" value="05cf70c1052486f0a592e43f419509834ae5af4e1c8bcc78489af1a5808b0f1a" name="vasadfs9ebcdefad7ce8d9">
<div class="alert alert-danger" id="registration-error-msg" style="display: none;"></div>
<div class="row">
<div class="col-md-6 hide">
<div class="form-group">
<label class="sr-only" for="account-firstName">City</label>
<input type="text" class="form-control" name="registrationForm[city]" id="city" placeholder="Paris">
<span class="help-block text-danger" id="account-city-error" style="display: none;"></span>
</div>
</div>
<div class="col-md-6">
<div class="form-group">
<label class="sr-only" for="account-firstName">First Name</label>
<input type="text" name="registrationForm[firstName]" placeholder="First Name" class="form-control" id="account-firstName" autocomplete="off">
<input type="hidden" value="cc78489af1a5firstName808b0f1a" name="cc78489af1a5808b0f1a">
<span class="help-block text-danger" id="account-firstName-error" style="display: none;"></span>
</div>
</div>
<div class="col-md-6">
<div class="form-group">
<label class="sr-only" for="account-lastName">Last Name</label>
<input type="text" name="registrationForm[lastName]" placeholder="Last Name" class="form-control" id="account-lastName" autocomplete="off">
<span class="help-block text-danger" id="account-lastName-error" style="display: none;"></span>
</div>
</div>
</div>
<div class="form-group">
<label class="sr-only" for="account-email">Email ID</label>
<input type="email" name="registrationForm[email]" placeholder="Email Id" class="form-control" id="account-email" autocomplete="off">
<span class="help-block text-danger" id="account-email-error" style="display: none;"></span>
</div>
<div class="form-group">
<label class="sr-only" for="account-password">Password</label>
<input type="password" name="registrationForm[password]" placeholder="Password" class="form-control" id="account-password" onblur="validatePassword();" autocomplete="off">
<span class="help-block text-danger" id="account-pass-error" style="display: none;"></span>
</div>
<div class="form-group">
<label class="sr-only" for="account-confirm-password">Confirm Password</label>
<input type="password" name="registrationForm[confirmPassword]" placeholder="Confirm Password" class="form-control" id="account-confirm-password" onblur="validatePassword();" autocomplete="off">
<span class="help-block text-danger" id="account-password-error" style="display: none;"></span>
</div>
<div class="form-group">
<label><input type="checkbox" value="Yes" name="registrationForm[is_newletter]"> Newsletter</label>
</div>
<div class="form-group">
<label><input type="checkbox" value="Yes" name="registrationForm[emagazine]"> E-magazine</label>
</div>
<div class="form-group">
<label><input type="checkbox" value="Yes" name="registrationForm[bio_info]"> Biospectrum Infomercial</label>
</div>
<div class="form-group">
<label><input type="checkbox" value="Yes" name="registrationForm[bio_reso]"> Bio Resource</label>
</div>
<div class="form-group">
<label><input type="checkbox" value="1" required=""> I accept the <a href="/pdf/terms-and-conditions.pdf" target="_blank">terms & condition</a> & <a href="/pdf/privacy-policy.pdf" target="_blank">Privacy policy</a></label>
</div>
<div class="row">
<div class="col-md-12">
<div class="form-group">
<button class="btn btn-success col-md-12" type="submit">Sign Up</button>
</div>
</div>
</div>
</form>
Name: forgotPasswordForm — POST /forgot-password/
<form role="form" action="/forgot-password/" method="post" name="forgotPasswordForm" id="forgotPasswordForm" onsubmit="return validateForgotPassword();" class="ng-pristine ng-valid">
<input type="hidden" value="05cf70c1052486f0a592e43f419509834ae5af4e1c8bcc78489af1a5808b0f1a" name="registration_csrfs9ebcdefad7ce8d9">
<input type="hidden" name="websitegh49ebcd78asd12a5sd">
<div class="alert alert-danger" id="forgot-pass-error-msg" style="display: none;"></div>
<div class="form-group">
<label class="sr-only" for="forgot-pass-email">Email id</label>
<input type="text" name="forgotPasswordForm[email]" placeholder="Email" class="form-control" id="forgot-pass-email">
<span class="help-block text-danger" id="forgot-pass-email-error" style="display: none;"></span>
</div>
<div class="row">
<div class="col-md-12">
<div class="form-group">
<button class="btn btn-success col-md-12" type="submit">Submit</button>
</div>
</div>
</div>
</form>
Name: newsletterForm — POST /newsletter-handle/
<form role="form" action="/newsletter-handle/" method="post" name="newsletterForm" id="newsletterForm" onsubmit="return validateNewsletter();" class="ng-pristine ng-valid">
<div class="alert alert-danger" id="newsletter-error-msg" style="display: none;"></div>
<div class="form-group">
<label class="sr-only" for="nl-email">Email ID </label>
<input type="email" name="newsletterForm[email]" placeholder="Email Id" class="form-control" id="nl-email">
<span class="help-block text-danger" id="nl-email-error" style="display: none;"></span>
</div>
<div class="form-group">
<label><input type="checkbox" value="1" required=""> I accept the <a href="/pdf/terms-and-conditions.pdf" target="_blank">terms & condition</a> & <a href="/pdf/privacy-policy.pdf" target="_blank">Privacy policy</a></label>
</div>
<div class="row">
<div class="col-md-12">
<div class="form-group">
<button class="btn btn-danger col-md-12" type="submit">SUBSCRIBE!</button>
</div>
</div>
</div>
</form>
Text Content
CONTINUE TO SITE OR WAIT 13 SECS Wednesday, 03 April 2024 * Subscribe * Newsletter * Webinars * Editorial Calendar 2024 * Media Kit Toggle navigation * HOME * Pharma * Generics * Drug Discovery * CMC & Manufacturing * Clinical Trials * New Drug Applications * BioTech * Biologics * Stem Cells * Vaccines * Therapeutics * MedTech * Medical Devices * Medical Diagnostic * BioServices * Contract Research * Clinical Research * Contract Manufacturing * Pre Clinical Development * Clinical Trial Phase * Healthcare * Digital Health * COVID19 * Artificial Intelligence * Bio LAB * Lab Products * Lab Safety * Lab Management * Lab Design * HER Health * Cell & Gene * Specials * Bio interaction * Premium Article * Biopreneurs * Industry Insights * Bio Money * Bio Informatics * Bio Jobs * Infomercial * Partner Content * BioSpectrum Asia Awards 2022 * Country * Australia * China * India * Japan * Korea * Malaysia * New Zealand * Singapore * Taiwan * Thailand * Indonesia * Vietnam * North America * World * Middle East countries * Europe * SAARC SINGAPORE AND INDONESIA DEEPEN COOPERATION IN EDUCATION WITH TWO NEW POSTGRADUATE SCHOLARSHIPS TAKARA BIO UNVEILS NGS PROFILING SYSTEM FOR ONCOLOGY BIOMARKER DISCOVERY SINGAPORE AND INDONESIA DEEPEN COOPERATION IN EDUCATION WITH TWO NEW POSTGRADUATE SCHOLARSHIPS TAKARA BIO UNVEILS NGS PROFILING SYSTEM FOR ONCOLOGY BIOMARKER DISCOVERY CMUH & MICROSOFT DEVELOP CHINESE SPEECH AI ENGINE APPLICATION FOR MEDICAL INSTITUTIONS IN TAIWAN AUSTRALIA SUGGESTS USE OF ULTRASOUND THERAPY AS PROMISING TREATMENT FOR ALZHEIMER’S DISEASE AGILENT LAUNCHES NEW ADVANCED DILUTION SYSTEM TO INCREASE LAB EFFICIENCY SINGAPORE AND INDONESIA DEEPEN COOPERATION IN EDUCATION WITH TWO NEW POSTGRADUATE SCHOLARSHIPS TAKARA BIO UNVEILS NGS PROFILING SYSTEM FOR ONCOLOGY BIOMARKER DISCOVERY CMUH & MICROSOFT DEVELOP CHINESE SPEECH AI ENGINE APPLICATION FOR MEDICAL INSTITUTIONS IN TAIWAN AUSTRALIA SUGGESTS USE OF ULTRASOUND THERAPY AS PROMISING TREATMENT FOR ALZHEIMER’S DISEASE AGILENT LAUNCHES NEW ADVANCED DILUTION SYSTEM TO INCREASE LAB EFFICIENCY News Feed * Singapore and Indonesia deepen cooperation in education with two new postgraduate scholarships * Takara Bio unveils NGS profiling system for oncology biomarker discovery * CMUH & Microsoft develop Chinese speech AI engine application for medical institutions in Taiwan * Australia suggests use of ultrasound therapy as promising treatment for Alzheimer’s disease * Agilent launches new advanced dilution system to increase lab efficiency * Korea leverages JLABS global network to enhance growth of biotech and medtech startups * National University of Singapore opens new research institute in China to incubate medtech startups * Researchers in Taiwan develop tool to accurately detect obstructive sleep apnea syndrome * Korean government to institute four healthcare reform tasks * FullCare Medical starts medical garment production at Tatu City, Kenya * Eisai to divest rights for Merislon and Myonal in Japan to Kaken Pharma for ¥ 3.8 B * Department of Health in Abu Dhabi lays focus on obesity prevention & management * Japanese pharma firms Eli Lilly, Nippon Shinyaku join hands to strengthen haematologic oncology field * Breakthrough antibiotic by Singapore shows promise against obstinate mycobacterial infections * Qiagen introduces QIAstat-Dx Analyzer 2.0 for enhancing collaboration across healthcare system * TCI Gene to enhance Malaysia's preventive healthcare in collaboration with ALPRO pharmacy * Japan's NTT and Olympus begin world’s first joint demo experiment of cloud endoscopy system * Indonesian government collaborates with Tanoto Foundation to improve primary healthcare services * Singapore supports development of AI-based clinical trial tool with S$50,000 * Korea expands healthcare cooperation with Turkmenistan, Paraguay, and Mongolia * Australia’s first purpose-built facility to deliver human challenge trials opens in Melbourne * Roche receives US FDA approval for first molecular test to screen for malaria in blood donors * Singapore invents coin-sized device to rapidly isolate blood plasma for diagnostics * China's Scivita Medical expands collaboration with Boston Scientific * Australian government grants TB Alliance award to improve access to new treatments for drug-resistant TB Most Popular * Cell & Gene | 01 April 2024 | Analysis Addressing Accessibility and Affordability of Cell & Gene Therapies The most sought-after and hot sector in the pharmaceutical industry, which has witnessed an outpouring of bill...Read more Singapore | 01 April 2024 | Opinion Addressing Challenges in Cell Therapy Manufacturing Cancer research has come a long way. Along with technology advancements, the basic options for treating cancer...Read more Cell & Gene | 01 April 2024 | Opinion Engineering CAR T-cell sharpshooters Ideally, the antigen for a traditional CAR T-cell (or a T-cell) would be universally and homogeneously express...Read more White paper / Reports | 01 April 2024 | Analysis Biotech and Pharma's March Shake-Up: Layoffs Signal Industry Evolution March 2024 has been marked by a series of layoffs in the biotech and pharmaceutical sector, raising concerns a...Read more Pharma News * Japan | 29 March 2024 | News Eisai to divest rights for Merislon and Myonal in Japan to Kaken Pharma for ¥ 3.8 B Eisai Co. has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment...Read more China | 19 February 2024 | News Biocytogen Pharma Beijing and Gilead enter into multi-target antibody collaboration agreement Biocytogen Pharmaceuticals (Beijing) Co. has announced an antibody evaluation and option agreement with A...Read more Korea | 07 February 2024 | News China's Luye Pharma partners with Korea-based Myung In Pharm to improve Alzheimer's related dementia treatment China-based Luye Pharma Group has entered into an agreement with South Korea's Myung In Pharm, granting the la...Read more BioTech News * India | 21 March 2024 | News Biological E to manufacture oral cholera vaccine for India and global markets South Korea-based International Vaccine Institute (IVI) has commenced a technology transfer of simplified Oral...Read more New Zealand | 08 March 2024 | News Kimer Med inks contract worth NZD $1.3 M to pioneer antiviral drug advances Kimer Med, a New Zealand (NZ)-based biotech startup, has signed a contract valued at up to $750,000 (NZD$1.3 m...Read more Australia | 04 March 2024 | News Australia to propel projects minimising antimicrobial resistance Australia’s leading national biotech incubator, CUREator by Brandon BioCatalyst, has announced the alloc...Read more MedTech News * Australia | 02 April 2024 | News Australia suggests use of ultrasound therapy as promising treatment for Alzheimer’s disease Australia's University of Queensland (UQ) researchers have found targeting amyloid plaque in the brain is not ...Read more Europe | 18 March 2024 | News Korean startup Lunit delivers AI-powered cancer screening solution to France and Portugal Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnostics and therape...Read more China | 15 March 2024 | News Scientists in Hong Kong invent non-invasive diagnostic device for chronic kidney disease A team of scientists at the Department of Health Technology and Informatics at the Hong Kong Polytechnic ...Read more BioServices News * Korea | 21 March 2024 | News Merck invests € 300+ M in new life science production site in Korea Merck invests more than €300 million into a new Bioprocessing Production Centre in Daejeon, South Korea. ...Read more Singapore | 19 March 2024 | News WuXi Biologics to establish new CRDMO facility in Singapore China's WuXi Biologics, a leading global Contract Research, Development and Manufacturing Organisation (CRDMO)...Read more Korea | 09 February 2024 | News Samsung Biologics & LegoChem Biosciences in Korea team up for ADC development South Korea-based Samsung Biologics, a global contract development and manufacturing organisation (CDMO), has ...Read more Video Gallery Inside Magazine Addressing Accessibility and Affordability of CELL & GENE THERAPIES Cell and gene therapies (CGT) are one of the hottest sectors in the pharmaceutical industry. Quite a few companies in the field are making remarkable advancements toward potentially curative treatments for challenging diseases using groundbreaking science. With lower R&D development costs than in advanced markets, China is becoming an attractive market for the development of CGT, and therefore may emerge as a strong competitor of overseas-made CGT, notes a GlobalData report. Bayer AG, recently announced the global expansion of its life science incubator network, Bayer Co. Lab, to Shanghai, China and Kobe, Japan. The new site in China will focus on oncology and CGT innovations. While India lags behind China in the production of cell and gene therapies, a wave of new biotech startups is emerging to address this challenge. Immuneel Therapeutics and ImmunoACT are currently developing CAR-T cell therapies. The latter’s NexCAR19 therapy received approval from India's Central Drug Standards Control Organisation (CDSCO) for treating relapsed or refractory B-cell lymphomas and leukaemia. Despite a steady stream of regulatory approvals and promising growth prospects, the high manufacturing costs associated with these therapies often render them inaccessible to the majority of patients. To address this issue, companies are actively striving to streamline and optimise the highly intricate and labour-intensive process of cell and gene therapy manufacturing. Click here to access E-magazine BioSpectrum Infomercial AUTOMATION & HIGH THROUGHPUT WITH SUEZ'S SIEVERS ECLIPSE BET PLATFORM * * * * PODCAST EDITORS PICKS Addressing Accessibility an... Can Test, Treat, Track Beat... “AI will be integrally invo... How Indian Biotech Investme... PREMIUM ARTICLE “We anticipate India will adopt dec “Because of its specificity and sel MOST READ Samsung Biologics signs MoU with Se Kimer Med inks contract worth NZD $ Queensland's Southern RNA joins for US FDA clears Beckman Coulter Life SURVEY BOX Is the APAC region addressing accessibility and affordability of cell & gene therapies? Yes No May be × Please select an option to participate in the poll. Vote View poll results More polls SUBSCRIBE TO BIOSPECTRUM ASIA SUBSCRIBE NOW! ENQUIRY Thanks for contacting us! We will get in touch with you shortly. Please fill the all fields. Name Email Enter a valid email address. Phone Message Send message CONTACT US 1 North Bridge Road, #08-08 High Street Centre, Singapore 179094 Email : communications@biospectrumasia.com +65 90150305 Visit Our Digital Magazine BioSpectrum India NuFFooDS Spectrum Privacy Policy Sitemap © 2024 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer Web Interface Conceived and Powered By : SCI Knowledge Interlinks HAVE AN ACCOUNT? * Login * Create Account * Forgot Password Login Email id Password Sign In Create Account City First Name Last Name Email ID Password Confirm Password Newsletter E-magazine Biospectrum Infomercial Bio Resource I accept the terms & condition & Privacy policy Sign Up Forgot Password Email id Submit Close × SUBSCRIBE TO OUR NEWSLETTER Email ID I accept the terms & condition & Privacy policy SUBSCRIBE! Close